FFC.AU · FarmaForce Limited

-

Please sign in to comment on FFC.AU

1 Comment

Admin

3 years, 7 months ago

FarmaForce Limited is currently in a long term downtrend where the price is trading 19.7% below its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.

FarmaForce Limited's total revenue sank by 6.9% to $6M since the same quarter in the previous year.

Its net income has increased by 124.8% to $577K since the same quarter in the previous year.

Finally, its free cash flow grew by 342.7% to $1M since the same quarter in the previous year.

Based on the above factors, FarmaForce Limited gets an overall score of 3/5.

Industry	Health Care Providers & Services
ISIN	AU000000FFC7
Sector	Healthcare
CurrencyCode	AUD
Exchange	AU

Beta	-0.37
Dividend Yield	0.0%
Target Price	None
PE Ratio	None
Market Cap	5M

ABOUT

FarmaForce Limited

Farmaforce Limited provides contract sales services to the pharmaceutical industry in Australia. The company operates in two segments, Contract Sales and Marketing Services to External Customers; and Services to Related Parties. It also offers sales, data, and medical affairs solutions. The company was incorporated in 2014 and is based in Sydney, Australia. Farmaforce Limited is a subsidiary of The iQ Group Global Ltd.

FFC.AU · FarmaForce Limited

-

FarmaForce Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest FarmaForce Limited using a moving average strategy